Savara Inc
Отворен
СекторЗдравеопазване
5.3 5.58
Преглед
Промяна на цената на акция
24 ч
Минимум
Максимум
Относно Savara Inc
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. is headquartered in Langhorne, Pennsylvania.
